203 related articles for article (PubMed ID: 28108637)
1.
Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
Neurology; 2017 Feb; 88(7):661-668. PubMed ID: 28108637
[TBL] [Abstract][Full Text] [Related]
2. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
[TBL] [Abstract][Full Text] [Related]
3. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
[TBL] [Abstract][Full Text] [Related]
4. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
[TBL] [Abstract][Full Text] [Related]
5. African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles.
Roses AD; Lutz MW; Saunders AM; Goldgaber D; Saul R; Sundseth SS; Akkari PA; Roses SM; Gottschalk WK; Whitfield KE; Vostrov AA; Hauser MA; Allingham RR; Burns DK; Chiba-Falek O; Welsh-Bohmer KA
Alzheimers Dement; 2014 Nov; 10(6):592-601.e2. PubMed ID: 25260913
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.
Yu L; Lutz MW; Farfel JM; Wilson RS; Burns DK; Saunders AM; De Jager PL; Barnes LL; Schneider JA; Bennett DA
Alzheimers Dement; 2017 Dec; 13(12):1380-1388. PubMed ID: 28624335
[TBL] [Abstract][Full Text] [Related]
7. TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.
Deters KD; Mormino EC; Yu L; Lutz MW; Bennett DA; Barnes LL
Alzheimers Dement; 2021 Aug; 17(8):1287-1296. PubMed ID: 33580752
[TBL] [Abstract][Full Text] [Related]
8. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.
Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE
Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136
[TBL] [Abstract][Full Text] [Related]
9. Characterization of
Nishimura A; Nonomura H; Tanaka S; Yoshida M; Maruyama Y; Aritomi Y; Saunders AM; Burns DK; Lutz MW; Runyan G; Lai E; Budur K; Roses AD
Alzheimers Dement (N Y); 2017 Nov; 3(4):524-530. PubMed ID: 29124110
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample.
Rajan KB; Barnes LL; Wilson RS; Weuve J; McAninch EA; Evans DA
J Am Geriatr Soc; 2019 Apr; 67(4):734-740. PubMed ID: 30584655
[TBL] [Abstract][Full Text] [Related]
11. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
[TBL] [Abstract][Full Text] [Related]
12. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.
Watts A; Wilkins HM; Michaelis E; Swerdlow RH
J Alzheimers Dis; 2019; 70(4):1059-1068. PubMed ID: 31322569
[TBL] [Abstract][Full Text] [Related]
13. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.
Schiepers OJ; Harris SE; Gow AJ; Pattie A; Brett CE; Starr JM; Deary IJ
Mol Psychiatry; 2012 Mar; 17(3):315-24. PubMed ID: 21263443
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
Honea RA; Hunt S; Lepping RJ; Vidoni ED; Morris JK; Watts A; Michaelis E; Burns JM; Swerdlow RH
Neurobiol Aging; 2023 Dec; 132():131-144. PubMed ID: 37804609
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
[TBL] [Abstract][Full Text] [Related]
16. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.
Hayden KM; McEvoy JM; Linnertz C; Attix D; Kuchibhatla M; Saunders AM; Lutz MW; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
Alzheimers Dement; 2012 Sep; 8(5):381-8. PubMed ID: 22863908
[TBL] [Abstract][Full Text] [Related]
17. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
[TBL] [Abstract][Full Text] [Related]
18. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
[TBL] [Abstract][Full Text] [Related]
19. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
20. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
